FDA Denies Approval of MDMA-Assisted Therapy for PTSD.
The American journal of nursing November 1, 2024 Karen Roush
The U.S. Food and Drug Administration declined to approve the use of MDMA-assisted therapy for PTSD, citing safety concerns and methodological problems in the clinical trials. The decision highlights ongoing debates about how to evaluate and regulate psychedelic treatments for mental health conditions.